BridgeBio Pharma, Inc. (2CL)
Market Closed
3 Jun, 20:00
XFRA 
€
54. 32
+0.49
+0.91%
€
- Market Cap
- P/E Ratio
- Div Yield
457 Volume
-3.85 Eps
€ 53.83
Previous Close Want to track 2CL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
2CL Earnings Reports FAQ
What is the earnings per share (EPS) for 2CL?
The current EPS is -3.85.
What is the company's earnings growth rate?
BridgeBio Pharma, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
BridgeBio Pharma, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for BridgeBio Pharma, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 2CL at this time, as BridgeBio Pharma, Inc has no recent EPS data to calculate it.
